Pathways for repairing and tolerating the spectrum of oxidative DNA lesions

Cancer Letters

Volumn 327, Issue 1-2, 2012, Pages 61-72

  Berquist, Brian R ^a   Wilson, David M ^b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Excision repair; Hereditary disorder; Interstrand crosslink; Oxidative DNA damage

Indexed keywords

APRATAXIN; DNA GLYCOSYLTRANSFERASE; DNA GLYCOSYLTRANSFERASE MYH; DNA POLYMERASE; PHOSPHATASE; PHOSPHODIESTERASE; POLYNUCLEOTIDE KINASE 3' PHOSPHATASE; PROTEIN; RNA POLYMERASE; RNA POLYMERASE II; TYROSYL DNA PHOSPHODIESTERASE 1; UNCLASSIFIED DRUG;

ATAXIA WITH OCULOMOTOR APRAXIA TYPE 1; ATYPICAL OXIDATIVE DNA DAMAGE; CANCER SUSCEPTIBILITY; CLASSIC OXIDATIVE DNA DAMAGE; COCKAYNE SYNDROME; COLON POLYPOSIS; DISEASE ASSOCIATION; DNA CROSS LINKING; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA TRANSCRIPTION; DOUBLE STRAND BREAK REPAIR; ENZYME ACTIVITY; EXCISION REPAIR; FANCONI ANEMIA; GENE; HUMAN; INTERSTRAND CROSSLINK REPAIR; MICROCEPHALY AND SIEZURE; MOLECULAR DYNAMICS; MUTAGENESIS; MYH ASSOCIATED COLORECTAL POLYPOSIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RECOMBINATION REPAIR; SHORT SURVEY; SINGLE STRAND BREAK REPAIR; SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY; TYROSYL DNA PHOSPHODIESTERASE 1 GENE; XERODERMA PIGMENTOSUM;

EID: 84867452253     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.02.001     Document Type: Review

References (166)

1. Imlay J.A., Linn S. DNA damage and oxygen radical toxicity. Science 1988, 240:1302-1309.
2. Mannaerts G.P., Van Veldhoven P.P. Metabolic pathways in mammalian peroxisomes. Biochimie 1993, 75:147-158.
3. Shen Z., Wu W., Hazen S.L. Activated leukocytes oxidatively damage DNA, RNA, and the nucleotide pool through halide-dependent formation of hydroxyl radical. Biochemistry 2000, 39:5474-5482.
4. Kovacic P., Wakelin L.P. Review: DNA molecular electrostatic potential: novel perspectives for the mechanism of action of anticancer drugs involving electron transfer and oxidative stress. Anticancer Drug Des. 2001, 16:175-184.
5. Wood M.L., Dizdaroglu M., Gajewski E., Essigmann J.M. Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome. Biochemistry 1990, 29:7024-7032.
6. Gajewski E., Rao G., Nackerdien Z., Dizdaroglu M. Modification of DNA bases in mammalian chromatin by radiation-generated free radicals. Biochemistry 1990, 29:7876-7882.
7. Raoul S., Bardet M., Cadet J. Gamma irradiation of 2'-deoxyadenosine in oxygen-free aqueous solutions: identification and conformational features of formamidopyrimidine nucleoside derivatives. Chem. Res. Toxicol. 1995, 8:924-933.
8. Tremblay S., Douki T., Cadet J., Wagner J.R. 2'-Deoxycytidine glycols, a missing link in the free radical-mediated oxidation of DNA. J. Biol. Chem. 1999, 274:20833-20838.
9. Dizdaroglu M., Holwitt E., Hagan M.P., Blakely W.F. Formation of cytosine glycol and 5,6-dihydroxycytosine in deoxyribonucleic acid on treatment with osmium tetroxide. Biochem. J. 1986, 235:531-536.
10. Teoule R., Bert C., Bonicel A. Thymine fragment damage retained in the DNA polynucleotide chain after gamma irradiation in aerated solutions II. Radiat. Res. 1977, 72:190-200.
11. Teebor G.W., Frenkel K., Goldstein M.S. Ionizing radiation and tritium transmutation both cause formation of 5-hydroxymethyl-2'-deoxyuridine in cellular DNA. Proc. Natl. Acad. Sci. USA 1984, 81:318-321.
12. Frenkel K., Cummings A., Solomon J., Cadet J., Steinberg J.J., Teebor G.W. Quantitative determination of the 5-(hydroxymethyl)uracil moiety in the DNA of gamma-irradiated cells. Biochemistry 1985, 24:4527-4533.
13. Lindahl T., Ljungquist S. Apurinic and apyrimidinic sites in DNA. Basic Life Sci. 1975, 5A:31-38.
14. Decarroz C., Wagner J.R., Cadet J. Specific deprotonation reactions of the pyrimidine radical cation resulting from the menadione mediated photosensitization of 2'-deoxycytidine. Free Radic. Res. Commun. 1987, 2:295-301.
15. Isildar M., Schuchmann M.N., Schulte-Frohlinde D., von Sonntag C. Gamma-radiolysis of DNA in oxygenated aqueous solutions: alterations at the sugar moiety. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1981, 40:347-354.
16. Henner W.D., Rodriguez L.O., Hecht S.M., Haseltine W.A. Gamma ray induced deoxyribonucleic acid strand breaks. 3' Glycolate termini. J. Biol. Chem. 1983, 258:711-713.
17. Bellon S., Ravanat J.L., Gasparutto D., Cadet J. Cross-linked thymine-purine base tandem lesions: synthesis, characterization, and measurement in gamma-irradiated isolated DNA. Chem. Res. Toxicol. 2002, 15:598-606.
18. Raleigh J.A., Kremers W., Whitehouse R. Radiation chemistry of nucleotides: 8,5'-cyclonucleotide formation and phosphate release initiated by hydroxyl radical attack on adenosine monophosphates. Radiat. Res. 1976, 65:414-422.
19. Miaskiewicz K., Miller J.H., Fuciarelli A.F. Theoretical analysis of DNA intrastrand cross linking by formation of 8,5'-cyclodeoxyadenosine. Nucleic Acids Res. 1995, 23:515-521.
20. Minko I.G., Kozekov I.D., Harris T.M., Rizzo C.J., Lloyd R.S., Stone M.P. Chemistry and biology of DNA containing 1,N(2)-deoxyguanosine adducts of the alpha, beta-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal. Chem. Res. Toxicol. 2009, 22:759-778.
21. Wang H., Kozekov I.D., Harris T.M., Rizzo C.J. Site-specific synthesis and reactivity of oligonucleotides containing stereochemically defined 1,N2-deoxyguanosine adducts of the lipid peroxidation product trans-4-hydroxynonenal. J. Am. Chem. Soc. 2003, 125:5687-5700.
22. Blair I.A. Lipid hydroperoxide-mediated DNA damage. Exp. Gerontol. 2001, 36:1473-1481.
23. Marnett L.J. Lipid peroxidation-DNA damage by malondialdehyde. Mutat. Res. 1999, 424:83-95.
24. Minetti C.A., Remeta D.P., Johnson F., Iden C.R., Breslauer K.J. Impact of alpha-hydroxy-propanodeoxyguanine adducts on DNA duplex energetics: opposite base modulation and implications for mutagenicity and genotoxicity. Biopolymers 2010, 93:370-382.
25. Cho Y.J., Wang H., Kozekov I.D., Kurtz A.J., Jacob J., Voehler M., Smith J., Harris T.M., Lloyd R.S., Rizzo C.J., Stone M.P. Stereospecific formation of interstrand carbinolamine DNA cross-links by crotonaldehyde- and acetaldehyde-derived alpha-CH3-gamma-OH-1,N2-propano-2'-deoxyguanosine adducts in the 5'-CpG-3' sequence. Chem. Res. Toxicol. 2006, 19:195-208.
26. Einolf H.J., Guengerich F.P. Fidelity of nucleotide insertion at 8-oxo-7,8-dihydroguanine by mammalian DNA polymerase delta. Steady-state and pre-steady-state kinetic analysis. J. Biol. Chem. 2001, 276:3764-3771.
27. Duarte V., Muller J.G., Burrows C.J. Insertion of dGMP and dAMP during in vitro DNA synthesis opposite an oxidized form of 7,8-dihydro-8-oxoguanine. Nucleic Acids Res. 1999, 27:496-502.
28. Sabouri N., Viberg J., Goyal D.K., Johansson E., Chabes A. Evidence for lesion bypass by yeast replicative DNA polymerases during DNA damage. Nucleic Acids Res. 2008, 36:5660-5667.
29. Shibutani S., Takeshita M., Grollman A.P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991, 349:431-434.
30. Zhang Y., Wu X., Rechkoblit O., Geacintov N.E., Taylor J.S., Wang Z. Response of human REV1 to different DNA damage: preferential dCMP insertion opposite the lesion. Nucleic Acids Res. 2002, 30:1630-1638.
31. Maga G., Villani G., Crespan E., Wimmer U., Ferrari E., Bertocci B., Hubscher U. 8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins. Nature 2007, 447:606-608.
32. Zhang Y., Wu X., Guo D., Rechkoblit O., Taylor J.S., Geacintov N.E., Wang Z. Lesion bypass activities of human DNA polymerase mu. J. Biol. Chem. 2002, 277:44582-44587.
33. Kamiya H., Satou K., Hori M., Yamaguchi A., Harashima H. Roles of specialized DNA polymerases in mutagenesis by oxidized guanine. Nucleic Acids Symp. Ser. (Oxf) 2009, 223-224.
34. Clark J.M., Beardsley G.P. Template length, sequence context, and 3'-5' exonuclease activity modulate replicative bypass of thymine glycol lesions in vitro. Biochemistry 1989, 28:775-779.
35. Belousova E.A., Maga G., Fan Y., Kubareva E.A., Romanova E.A., Lebedeva N.A., Oretskaya T.S., Lavrik O.I. DNA polymerases beta and lambda bypass thymine glycol in gapped DNA structures. Biochemistry 2010, 49:4695-4704.
36. Kusumoto R., Masutani C., Iwai S., Hanaoka F. Translesion synthesis by human DNA polymerase eta across thymine glycol lesions. Biochemistry 2002, 41:6090-6099.
37. Fischhaber P.L., Gerlach V.L., Feaver W.J., Hatahet Z., Wallace S.S., Friedberg E.C. Human DNA polymerase kappa bypasses and extends beyond thymine glycols during translesion synthesis in vitro, preferentially incorporating correct nucleotides. J. Biol. Chem. 2002, 277:37604-37611.
38. Yoon J.H., Bhatia G., Prakash S., Prakash L. Error-free replicative bypass of thymine glycol by the combined action of DNA polymerases kappa and zeta in human cells. Proc. Natl. Acad. Sci. USA 2010, 107:14116-14121.
39. Seki M., Masutani C., Yang L.W., Schuffert A., Iwai S., Bahar I., Wood R.D. High-efficiency bypass of DNA damage by human DNA polymerase Q. EMBO J. 2004, 23:4484-4494.
40. Takata K., Shimizu T., Iwai S., Wood R.D. Human DNA polymerase N (POLN) is a low fidelity enzyme capable of error-free bypass of 5S-thymine glycol. J. Biol. Chem. 2006, 281:23445-23455.
41. Vaisman A., Woodgate R. Unique misinsertion specificity of poliota may decrease the mutagenic potential of deaminated cytosines. EMBO J. 2001, 20:6520-6529.
42. Choi J.Y., Lim S., Kim E.J., Jo A., Guengerich F.P. Translesion synthesis across abasic lesions by human B-family and Y-family DNA polymerases alpha, delta, eta, iota, kappa, and REV1. J. Mol. Biol. 2010, 404:34-44.
43. Colis L.C., Raychaudhury P., Basu A.K. Mutational specificity of gamma-radiation-induced guanine-thymine and thymine-guanine intrastrand cross-links in mammalian cells and translesion synthesis past the guanine-thymine lesion by human DNA polymerase eta. Biochemistry 2008, 47:8070-8079.
44. Kuraoka I., Robins P., Masutani C., Hanaoka F., Gasparutto D., Cadet J., Wood R.D., Lindahl T. Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase eta and resistance to exonuclease action at cyclopurine deoxynucleoside residues. J. Biol. Chem. 2001, 276:49283-49288.
45. Perrino F.W., Harvey S., Blans P., Gelhaus S., Lacourse W.R., Fishbein J.C. Polymerization past the N2-isopropylguanine and the N6-isopropyladenine DNA lesions with the translesion synthesis DNA polymerases eta and iota and the replicative DNA polymerase alpha. Chem. Res. Toxicol. 2005, 18:1451-1461.
46. Hang B., Chenna A., Guliaev A.B., Singer B. Miscoding properties of 1,N6-ethanoadenine, a DNA adduct derived from reaction with the antitumor agent 1,3-bis(2-chloroethyl)-1-nitrosourea. Mutat. Res. 2003, 531:191-203.
47. Choi J.Y., Zang H., Angel K.C., Kozekov I.D., Goodenough A.K., Rizzo C.J., Guengerich F.P. Translesion synthesis across 1,N2-ethenoguanine by human DNA polymerases. Chem. Res. Toxicol. 2006, 19:879-886.
48. Minko I.G., Washington M.T., Kanuri M., Prakash L., Prakash S., Lloyd R.S. Translesion synthesis past acrolein-derived DNA adduct, gamma-hydroxypropanodeoxyguanosine, by yeast and human DNA polymerase eta. J. Biol. Chem. 2003, 278:784-790.
49. Minko I.G., Harbut M.B., Kozekov I.D., Kozekova A., Jakobs P.M., Olson S.B., Moses R.E., Harris T.M., Rizzo C.J., Lloyd R.S. Role for DNA polymerase kappa in the processing of N2-N2-guanine interstrand cross-links. J. Biol. Chem. 2008, 283:17075-17082.
50. Minko I.G., Kozekov I.D., Kozekova A., Harris T.M., Rizzo C.J., Lloyd R.S. Mutagenic potential of DNA-peptide crosslinks mediated by acrolein-derived DNA adducts. Mutat. Res. 2008, 637:161-172.
51. Charlet-Berguerand N., Feuerhahn S., Kong S.E., Ziserman H., Conaway J.W., Conaway R., Egly J.M. RNA polymerase II bypass of oxidative DNA damage is regulated by transcription elongation factors. EMBO J. 2006, 25:5481-5491.
52. Bregeon D., Peignon P.A., Sarasin A. Transcriptional mutagenesis induced by 8-oxoguanine in mammalian cells. PLoS Genet. 2009, 5:e1000577.
53. Saxowsky T.T., Meadows K.L., Klungland A., Doetsch P.W. 8-Oxoguanine-mediated transcriptional mutagenesis causes Ras activation in mammalian cells. Proc. Natl. Acad. Sci. USA 2008, 105:18877-18882.
54. Marietta C., Brooks P.J. Transcriptional bypass of bulky DNA lesions causes new mutant RNA transcripts in human cells. EMBO Rep. 2007, 8:388-393.
55. Cheng T.F., Hu X., Gnatt A., Brooks P.J. Differential blocking effects of the acetaldehyde-derived DNA lesion N2-ethyl-2'-deoxyguanosine on transcription by multisubunit and single subunit RNA polymerases. J. Biol. Chem. 2008, 283:27820-27828.
56. Brooks P.J., Cheng T.F., Cooper L. Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?. DNA Repair (Amst) 2008, 7:834-848.
57. Sobol R.W., Horton J.K., Kuhn R., Gu H., Singhal R.K., Prasad R., Rajewsky K., Wilson S.H. Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature 1996, 379:183-186.
58. Meira L.B., Devaraj S., Kisby G.E., Burns D.K., Daniel R.L., Hammer R.E., Grundy S., Jialal I., Friedberg E.C. Heterozygosity for the mouse Apex gene results in phenotypes associated with oxidative stress. Cancer Res. 2001, 61:5552-5557.
59. Tebbs R.S., Flannery M.L., Meneses J.J., Hartmann A., Tucker J.D., Thompson L.H., Cleaver J.E., Pedersen R.A. Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Dev. Biol. 1999, 208:513-529.
60. Bentley D., Selfridge J., Millar J.K., Samuel K., Hole N., Ansell J.D., Melton D.W. DNA ligase I is required for fetal liver erythropoiesis but is not essential for mammalian cell viability. Nat. Genet. 1996, 13:489-491.
61. Puebla-Osorio N., Lacey D.B., Alt F.W., Zhu C. Early embryonic lethality due to targeted inactivation of DNA ligase III. Mol. Cell Biol. 2006, 26:3935-3941.
62. Klungland A., Rosewell I., Hollenbach S., Larsen E., Daly G., Epe B., Seeberg E., Lindahl T., Barnes D.E. Accumulation of premutagenic DNA lesions in mice defective in removal of oxidative base damage. Proc. Natl. Acad. Sci. USA 1999, 96:13300-13305.
63. Xie Y., Yang H., Cunanan C., Okamoto K., Shibata D., Pan J., Barnes D.E., Lindahl T., McIlhatton M., Fishel R., Miller J.H. Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumors. Cancer Res. 2004, 64:3096-3102.
64. Russo M.T., De Luca G., Degan P., Parlanti E., Dogliotti E., Barnes D.E., Lindahl T., Yang H., Miller J.H., Bignami M. Accumulation of the oxidative base lesion 8-hydroxyguanine in DNA of tumor-prone mice defective in both the Myh and Ogg1 DNA glycosylases. Cancer Res. 2004, 64:4411-4414.
65. Takao M., Kanno S., Shiromoto T., Hasegawa R., Ide H., Ikeda S., Sarker A.H., Seki S., Xing J.Z., Le X.C., Weinfeld M., Kobayashi K., Miyazaki J., Muijtjens M., Hoeijmakers J.H., van der Horst G., Yasui A. Novel nuclear and mitochondrial glycosylases revealed by disruption of the mouse Nth1 gene encoding an endonuclease III homolog for repair of thymine glycols. EMBO J. 2002, 21:3486-3493.
66. Ocampo M.T., Chaung W., Marenstein D.R., Chan M.K., Altamirano A., Basu A.K., Boorstein R.J., Cunningham R.P., Teebor G.W. Targeted deletion of mNth1 reveals a novel DNA repair enzyme activity. Mol. Cell Biol. 2002, 22:6111-6121.
67. Vartanian V., Lowell B., Minko I.G., Wood T.G., Ceci J.D., George S., Ballinger S.W., Corless C.L., McCullough A.K., Lloyd R.S. The metabolic syndrome resulting from a knockout of the NEIL1 DNA glycosylase. Proc. Natl. Acad. Sci. USA 2006, 103:1864-1869.
68. Chan M.K., Ocampo-Hafalla M.T., Vartanian V., Jaruga P., Kirkali G., Koenig K.L., Brown S., Lloyd R.S., Dizdaroglu M., Teebor G.W. Targeted deletion of the genes encoding NTH1 and NEIL1 DNA N-glycosylases reveals the existence of novel carcinogenic oxidative damage to DNA. DNA Repair (Amst) 2009, 8:786-794.
69. Huamani J., McMahan C.A., Herbert D.C., Reddick R., McCarrey J.R., MacInnes M.I., Chen D.J., Walter C.A. Spontaneous mutagenesis is enhanced in Apex heterozygous mice. Mol. Cell Biol. 2004, 24:8145-8153.
70. Cabelof D.C., Guo Z., Raffoul J.J., Sobol R.W., Wilson S.H., Richardson A., Heydari A.R. Base excision repair deficiency caused by polymerase beta haploinsufficiency: accelerated DNA damage and increased mutational response to carcinogens. Cancer Res. 2003, 63:5799-5807.
71. Cabelof D.C., Ikeno Y., Nyska A., Busuttil R.A., Anyangwe N., Vijg J., Matherly L.H., Tucker J.D., Wilson S.H., Richardson A., Heydari A.R. Haploinsufficiency in DNA polymerase beta increases cancer risk with age and alters mortality rate. Cancer Res. 2006, 66:7460-7465.
72. McNeill D.R., Lin P.C., Miller M.G., Pistell P.J., de Souza-Pinto N.C., Fishbein K.W., Spencer R.G., Liu Y., Pettan-Brewer C., Ladiges W.C., Wilson D.M. XRCC1 haploinsufficiency in mice has little effect on aging, but adversely modifies exposure-dependent susceptibility. Nucleic Acids Res. 2011, 39:7992-8004.
73. Baglioni S., Melean G., Gensini F., Santucci M., Scatizzi M., Papi L., Genuardi M. A kindred with MYH-associated polyposis and pilomatricomas. Am. J. Med. Genet. A 2005, 134A:212-214.
74. Imai K., Slupphaug G., Lee W.I., Revy P., Nonoyama S., Catalan N., Yel L., Forveille M., Kavli B., Krokan H.E., Ochs H.D., Fischer A., Durandy A. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat. Immunol. 2003, 4:1023-1028.
75. Kavli B., Andersen S., Otterlei M., Liabakk N.B., Imai K., Fischer A., Durandy A., Krokan H.E., Slupphaug G. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil. J. Exp. Med. 2005, 201:2011-2021.
76. Wilson D.M., Kim D., Berquist B.R., Sigurdson A.J. Variation in base excision repair capacity. Mutat Res. 2011, 711:100-112.
77. Nemec A.A., Wallace S.S., Sweasy J.B. Variant base excision repair proteins: contributors to genomic instability. Semin. Cancer Biol. 2010, 20:320-328.
78. Takashima H., Boerkoel C.F., John J., Saifi G.M., Salih M.A., Armstrong D., Mao Y., Quiocho F.A., Roa B.B., Nakagawa M., Stockton D.W., Lupski J.R. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat. Genet. 2002, 32:267-272.
79. Interthal H., Pouliot J.J., Champoux J.J. The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc. Natl. Acad. Sci. USA 2001, 98:12009-12014.
80. Inamdar K.V., Pouliot J.J., Zhou T., Lees-Miller S.P., Rasouli-Nia A., Povirk L.F. Conversion of phosphoglycolate to phosphate termini on 3' overhangs of DNA double strand breaks by the human tyrosyl-DNA phosphodiesterase hTdp1. J. Biol. Chem. 2002, 277:27162-27168.
81. Walton C., Interthal H., Hirano R., Salih M.A., Takashima H., Boerkoel C.F. Spinocerebellar ataxia with axonal neuropathy. Adv. Exp. Med. Biol. 2010, 685:75-83.
82. Shen J., Gilmore E.C., Marshall C.A., Haddadin M., Reynolds J.J., Eyaid W., Bodell A., Barry B., Gleason D., Allen K., Ganesh V.S., Chang B.S., Grix A., Hill R.S., Topcu M., Caldecott K.W., Barkovich A.J., Walsh C.A. Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat. Genet. 2010, 42:245-249.
83. Jilani A., Ramotar D., Slack C., Ong C., Yang X.M., Scherer S.W., Lasko D.D. Molecular cloning of the human gene, PNKP, encoding a polynucleotide kinase 3'-phosphatase and evidence for its role in repair of DNA strand breaks caused by oxidative damage. J. Biol. Chem. 1999, 274:24176-24186.
84. Moreira M.C., Barbot C., Tachi N., Kozuka N., Uchida E., Gibson T., Mendonca P., Costa M., Barros J., Yanagisawa T., Watanabe M., Ikeda Y., Aoki M., Nagata T., Coutinho P., Sequeiros J., Koenig M. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat. Genet. 2001, 29:189-193.
85. Date H., Onodera O., Tanaka H., Iwabuchi K., Uekawa K., Igarashi S., Koike R., Hiroi T., Yuasa T., Awaya Y., Sakai T., Takahashi T., Nagatomo H., Sekijima Y., Kawachi I., Takiyama Y., Nishizawa M., Fukuhara N., Saito K., Sugano S., Tsuji S. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene. Nat. Genet. 2001, 29:184-188.
86. Ahel I., Rass U., El-Khamisy S.F., Katyal S., Clements P.M., McKinnon P.J., Caldecott K.W., West S.C. The neurodegenerative disease protein aprataxin resolves abortive DNA ligation intermediates. Nature 2006, 443:713-716.
87. P. Coutinho, C. Barbot, Ataxia with Oculomotor Apraxia Type 1, in: R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, (Eds.), GeneReviews, Seattle (WA), 1993.
88. Lehmann A.R., McGibbon D., Stefanini M. Xeroderma pigmentosum. Orphanet J. Rare Dis. 2011, 6:70.
89. K.H. Kraemer, J.J. DiGiovanna, Xeroderma Pigmentosum, in: R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, (Eds.), GeneReviews, Seattle (WA), 1993.
90. Su X., Huang J. The Fanconi anemia pathway and DNA interstrand cross-link repair. Protein Cell 2011, 2:704-711.
91. Kamenisch Y., Berneburg M. Progeroid syndromes and UV-induced oxidative DNA damage. J. Investig. Dermatol. Symp. Proc. 2009, 14:8-14.
92. Bradford P.T., Goldstein A.M., Tamura D., Khan S.G., Ueda T., Boyle J., Oh K.S., Imoto K., Inui H., Moriwaki S., Emmert S., Pike K.M., Raziuddin A., Plona T.M., DiGiovanna J.J., Tucker M.A., Kraemer K.H. Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J. Med. Genet. 2011, 48:168-176.
93. Brooks P.J. The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair. DNA Repair (Amst) 2008, 7:1168-1179.
94. Gopalakrishnan K., Low G.K., Ting A.P., Srikanth P., Slijepcevic P., Hande M.P. Hydrogen peroxide induced genomic instability in nucleotide excision repair-deficient lymphoblastoid cells. Genome Integr. 2010, 1:16.
95. Low G.K., Fok E.D., Ting A.P., Hande M.P. Oxidative damage induced genotoxic effects in human fibroblasts from Xeroderma Pigmentosum group A patients. Int. J. Biochem. Cell Biol. 2008, 40:2583-2595.
96. D'Errico M., Parlanti E., Teson M., de Jesus B.M., Degan P., Calcagnile A., Jaruga P., Bjoras M., Crescenzi M., Pedrini A.M., Egly J.M., Zambruno G., Stefanini M., Dizdaroglu M., Dogliotti E. New functions of XPC in the protection of human skin cells from oxidative damage. EMBO J. 2006, 25:4305-4315.
97. Brooks P.J. The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum. Neuroscience 2007, 145:1407-1417.
98. Bessho T. Nucleotide excision repair 3' endonuclease XPG stimulates the activity of base excision repairenzyme thymine glycol DNA glycosylase. Nucleic Acids Res. 1999, 27:979-983.
99. Klungland A., Hoss M., Gunz D., Constantinou A., Clarkson S.G., Doetsch P.W., Bolton P.H., Wood R.D., Lindahl T. Base excision repair of oxidative DNA damage activated by XPG protein. Mol. Cell 1999, 3:33-42.
100. Hanawalt P.C., Spivak G. Transcription-coupled DNA repair: two decades of progress and surprises. Nat. Rev. Mol. Cell Biol. 2008, 9:958-970.
101. Cramers P., Verhoeven E.E., Filon A.R., Rockx D.A., Santos S.J., van der Leer A.A., Kleinjans J.C., van Zeeland A.A., Mullenders L.H. Impaired repair of ionizing radiation-induced DNA damage in Cockayne syndrome cells. Radiat. Res. 2011, 175:432-443.
102. Tuo J., Jaruga P., Rodriguez H., Bohr V.A., Dizdaroglu M. Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress. FASEB J. 2003, 17:668-674.
103. Tuo J., Jaruga P., Rodriguez H., Dizdaroglu M., Bohr V.A. The cockayne syndrome group B gene product is involved in cellular repair of 8-hydroxyadenine in DNA. J. Biol. Chem. 2002, 277:30832-30837.
104. Tuo J., Muftuoglu M., Chen C., Jaruga P., Selzer R.R., Brosh R.M., Rodriguez H., Dizdaroglu M., Bohr V.A. The Cockayne Syndrome group B gene product is involved in general genome base excision repair of 8-hydroxyguanine in DNA. J. Biol. Chem. 2001, 276:45772-45779.
105. Spivak G., Hanawalt P.C. Host cell reactivation of plasmids containing oxidative DNA lesions is defective in Cockayne syndrome but normal in UV-sensitive syndrome fibroblasts. DNA Repair (Amst) 2006, 5:13-22.
106. Ropolo M., Degan P., Foresta M., D'Errico M., Lasiglie D., Dogliotti E., Casartelli G., Zupo S., Poggi A., Frosina G. Complementation of the oxidatively damaged DNA repair defect in Cockayne syndrome A and B cells by Escherichia coli formamidopyrimidine DNA glycosylase. Free Radic. Biol. Med. 2007, 42:1807-1817.
107. D'Errico M., Parlanti E., Teson M., Degan P., Lemma T., Calcagnile A., Iavarone I., Jaruga P., Ropolo M., Pedrini A.M., Orioli D., Frosina G., Zambruno G., Dizdaroglu M., Stefanini M., Dogliotti E. The role of CSA in the response to oxidative DNA damage in human cells. Oncogene 2007, 26:4336-4343.
108. Osenbroch P.O., Auk-Emblem P., Halsne R., Strand J., Forstrom R.J., van der Pluijm I., Eide L. Accumulation of mitochondrial DNA damage and bioenergetic dysfunction in CSB defective cells. FEBS J. 2009, 276:2811-2821.
109. Muftuoglu M., de Souza-Pinto N.C., Dogan A., Aamann M., Stevnsner T., Rybanska I., Kirkali G., Dizdaroglu M., Bohr V.A. Cockayne syndrome group B protein stimulates repair of formamidopyrimidines by NEIL1 DNA glycosylase. J. Biol. Chem. 2009, 284:9270-9279.
110. Thorslund T., von Kobbe C., Harrigan J.A., Indig F.E., Christiansen M., Stevnsner T., Bohr V.A. Cooperation of the Cockayne syndrome group B protein and poly(ADP-ribose) polymerase 1 in the response to oxidative stress. Mol. Cell Biol. 2005, 25:7625-7636.
111. Wong H.K., Muftuoglu M., Beck G., Imam S.Z., Bohr V.A., Wilson D.M. Cockayne syndrome B protein stimulates apurinic endonuclease 1 activity and protects against agents that introduce base excision repair intermediates. Nucleic Acids Res. 2007, 35:4103-4113.
112. Hoeijmakers J.H. DNA damage, aging, and cancer. N. Engl. J. Med. 2009, 361:1475-1485.
113. D'Andrea A.D. Susceptibility pathways in Fanconi's anemia and breast cancer. N. Engl. J. Med. 2010, 362:1909-1919.
114. Deans A.J., West S.C. DNA interstrand crosslink repair and cancer. Nat. Rev. Cancer 2011, 11:467-480.
115. Jones J.C., Zhen W.P., Reed E., Parker R.J., Sancar A., Bohr V.A. Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cells. J. Biol. Chem. 1991, 266:7101-7107.
116. May A., Nairn R.S., Okumoto D.S., Wassermann K., Stevnsner T., Jones J.C., Bohr V.A. Repair of individual DNA strands in the hamster dihydrofolate reductase gene after treatment with ultraviolet light, alkylating agents, and cisplatin. J. Biol. Chem. 1993, 268:1650-1657.
117. Islas A.L., Baker F.J., Hanawalt P.C. Transcription-coupled repair of psoralen cross-links but not monoadducts in Chinese hamster ovary cells. Biochemistry 1994, 33:10794-10799.
118. Vos J.M., Hanawalt P.C. Processing of psoralen adducts in an active human gene: repair and replication of DNA containing monoadducts and interstrand cross-links. Cell 1987, 50:789-799.
119. Sala-Trepat M., Rouillard D., Escarceller M., Laquerbe A., Moustacchi E., Papadopoulo D. Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp. Cell Res. 2000, 260:208-215.
120. Rothfuss A., Grompe M. Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell Biol. 2004, 24:123-134.
121. McHugh P.J., Sones W.R., Hartley J.A. Repair of intermediate structures produced at DNA interstrand cross-links in Saccharomyces cerevisiae. Mol. Cell Biol. 2000, 20:3425-3433.
122. Raschle M., Knipscheer P., Enoiu M., Angelov T., Sun J., Griffith J.D., Ellenberger T.E., Scharer O.D., Walter J.C. Mechanism of replication-coupled DNA interstrand crosslink repair. Cell 2008, 134:969-980.
123. Gari K., Decaillet C., Delannoy M., Wu L., Constantinou A. Remodeling of DNA replication structures by the branch point translocase FANCM. Proc. Natl. Acad. Sci. USA 2008, 105:16107-16112.
124. Gari K., Decaillet C., Stasiak A.Z., Stasiak A., Constantinou A. The Fanconi anemia protein FANCM can promote branch migration of Holliday junctions and replication forks. Mol. Cell 2008, 29:141-148.
125. Meetei A.R., de Winter J.P., Medhurst A.L., Wallisch M., Waisfisz Q., van de Vrugt H.J., Oostra A.B., Yan Z., Ling C., Bishop C.E., Hoatlin M.E., Joenje H., Wang W. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet. 2003, 35:165-170.
126. Meetei A.R., Yan Z., Wang W. FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle 2004, 3:179-181.
127. Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C., Hejna J., Grompe M., D'Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 2001, 7:249-262.
128. Smogorzewska A., Matsuoka S., Vinciguerra P., McDonald E.R., Hurov K.E., Luo J., Ballif B.A., Gygi S.P., Hofmann K., D'Andrea A.D., Elledge S.J. Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair. Cell 2007, 129:289-301.
129. Sims A.E., Spiteri E., Sims R.J., Arita A.G., Lach F.P., Landers T., Wurm M., Freund M., Neveling K., Hanenberg H., Auerbach A.D., Huang T.T. FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 2007, 14:564-567.
130. Yuan F., El Hokayem J., Zhou W., Zhang Y. FANCI protein binds to DNA and interacts with FANCD2 to recognize branched structures. J. Biol. Chem. 2009, 284:24443-24452.
131. Longerich S., San Filippo J., Liu D., Sung P. FANCI binds branched DNA and is monoubiquitinated by UBE2T-FANCL. J. Biol. Chem. 2009, 284:23182-23186.
132. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., Ikeda H., Fox E.A., D'Andrea A.D. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002, 297:606-609.
133. Reid S., Schindler D., Hanenberg H., Barker K., Hanks S., Kalb R., Neveling K., Kelly P., Seal S., Freund M., Wurm M., Batish S.D., Lach F.P., Yetgin S., Neitzel H., Ariffin H., Tischkowitz M., Mathew C.G., Auerbach A.D., Rahman N. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat. Genet. 2007, 39:162-164.
134. Kim Y., Lach F.P., Desetty R., Hanenberg H., Auerbach A.D., Smogorzewska A. Mutations of the SLX4 gene in Fanconi anemia. Nat. Genet. 2011, 43:142-146.
135. Crossan G.P., van der Weyden L., Rosado I.V., Langevin F., Gaillard P.H., McIntyre R.E., Gallagher F., Kettunen M.I., Lewis D.Y., Brindle K., Arends M.J., Adams D.J., Patel K.J. Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia. Nat. Genet. 2011, 43:147-152.
136. Stoepker C., Hain K., Schuster B., Hilhorst-Hofstee Y., Rooimans M.A., Steltenpool J., Oostra A.B., Eirich K., Korthof E.T., Nieuwint A.W., Jaspers N.G., Bettecken T., Joenje H., Schindler D., Rouse J., de Winter J.P. SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat. Genet. 2011, 43:138-141.
137. Vaz F., Hanenberg H., Schuster B., Barker K., Wiek C., Erven V., Neveling K., Endt D., Kesterton I., Autore F., Fraternali F., Freund M., Hartmann L., Grimwade D., Roberts R.G., Schaal H., Mohammed S., Rahman N., Schindler D., Mathew C.G. Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet. 2010, 42:406-409.
138. Hussain S., Wilson J.B., Medhurst A.L., Hejna J., Witt E., Ananth S., Davies A., Masson J.Y., Moses R., West S.C., de Winter J.P., Ashworth A., Jones N.J., Mathew C.G. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet. 2004, 13:1241-1248.
139. Digweed M., Rothe S., Demuth I., Scholz R., Schindler D., Stumm M., Grompe M., Jordan A., Sperling K. Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis 2002, 23:1121-1126.
140. Howlett N.G., Taniguchi T., Durkin S.G., D'Andrea A.D., Glover T.W. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Genet. 2005, 14:693-701.
141. Yamamoto K.N., Kobayashi S., Tsuda M., Kurumizaka H., Takata M., Kono K., Jiricny J., Takeda S., Hirota K. Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway. Proc. Natl. Acad. Sci. USA 2011, 108:6492-6496.
142. Munoz I.M., Hain K., Declais A.C., Gardiner M., Toh G.W., Sanchez-Pulido L., Heuckmann J.M., Toth R., Macartney T., Eppink B., Kanaar R., Ponting C.P., Lilley D.M., Rouse J. Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair. Mol. Cell 2009, 35:116-127.
143. Hanada K., Budzowska M., Modesti M., Maas A., Wyman C., Essers J., Kanaar R. The structure-specific endonuclease Mus81-Eme1 promotes conversion of interstrand DNA crosslinks into double-strands breaks. EMBO J. 2006, 25:4921-4932.
144. Bhagwat N., Olsen A.L., Wang A.T., Hanada K., Stuckert P., Kanaar R., D'Andrea A., Niedernhofer L.J., McHugh P.J. XPF-ERCC1 participates in the Fanconi anemia pathway of cross-link repair. Mol. Cell Biol. 2009, 29:6427-6437.
145. MacKay C., Declais A.C., Lundin C., Agostinho A., Deans A.J., MacArtney T.J., Hofmann K., Gartner A., West S.C., Helleday T., Lilley D.M., Rouse J. Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2. Cell 2010, 142:65-76.
146. Kratz K., Schopf B., Kaden S., Sendoel A., Eberhard R., Lademann C., Cannavo E., Sartori A.A., Hengartner M.O., Jiricny J. Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents. Cell 2010, 142:77-88.
147. Smogorzewska A., Desetty R., Saito T.T., Schlabach M., Lach F.P., Sowa M.E., Clark A.B., Kunkel T.A., Harper J.W., Colaiacovo M.P., Elledge S.J. A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair. Mol. Cell 2010, 39:36-47.
148. Mirchandani K.D., McCaffrey R.M., D'Andrea A.D. The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. DNA Repair (Amst) 2008, 7:902-911.
149. Hicks J.K., Chute C.L., Paulsen M.T., Ragland R.L., Howlett N.G., Gueranger Q., Glover T.W., Canman C.E. Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links. Mol. Cell Biol. 2010, 30:1217-1230.
150. Masuda Y., Ohmae M., Masuda K., Kamiya K. Structure and enzymatic properties of a stable complex of the human REV1 and REV7 proteins. J. Biol. Chem. 2003, 278:12356-12360.
151. Hlavin E.M., Smeaton M.B., Noronha A.M., Wilds C.J., Miller P.S. Cross-link structure affects replication-independent DNA interstrand cross-link repair in mammalian cells. Biochemistry 2010, 49:3977-3988.
152. Cipak L., Watanabe N., Bessho T. The role of BRCA2 in replication-coupled DNA interstrand cross-link repair in vitro. Nat. Struct. Mol. Biol. 2006, 13:729-733.
153. Couve S., Mace-Aime G., Rosselli F., Saparbaev M.K. The human oxidative DNA glycosylase NEIL1 excises psoralen-induced interstrand DNA cross-links in a three-stranded DNA structure. J. Biol. Chem. 2009, 284:11963-11970.
154. Couve-Privat S., Mace G., Rosselli F., Saparbaev M.K. Psoralen-induced DNA adducts are substrates for the base excision repair pathway in human cells. Nucleic Acids Res. 2007, 35:5672-5682.
155. Mace-Aime G., Couve S., Khassenov B., Rosselli F., Saparbaev M.K. The Fanconi anemia pathway promotes DNA glycosylase-dependent excision of interstrand DNA crosslinks. Environ. Mol. Mutagen 2010, 51:508-519.
156. Joenje H., Arwert F., Eriksson A.W., de Koning H., Oostra A.B. Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia. Nature 1981, 290:142-143.
157. Schindler D., Hoehn H. Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am. J. Hum. Genet. 1988, 43:429-435.
158. Saadatzadeh M.R., Bijangi-Vishehsaraei K., Hong P., Bergmann H., Haneline L.S. Oxidant hypersensitivity of Fanconi anemia type C-deficient cells is dependent on a redox-regulated apoptotic pathway. J. Biol. Chem. 2004, 279:16805-16812.
159. Zhang X., Sejas D.P., Qiu Y., Williams D.A., Pang Q. Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence. J. Cell Sci. 2007, 120:1572-1583.
160. Zhang X., Li J., Sejas D.P., Pang Q. Hypoxia-reoxygenation induces premature senescence in FA bone marrow hematopoietic cells. Blood 2005, 106:75-85.
161. Cadet J., Douki T., Ravanat J.L. Oxidatively generated base damage to cellular DNA. Free Radic. Biol. Med. 2010, 49:9-21.
162. Evans M.D., Dizdaroglu M., Cooke M.S. Oxidative DNA damage and disease: induction, repair and significance. Mutat. Res. 2004, 567:1-61.
163. Ward J.F. The complexity of DNA damage: relevance to biological consequences. Int. J. Radiat. Biol. 1994, 66:427-432.
164. Kryston T.B., Georgiev A.B., Pissis P., Georgakilas A.G. Role of oxidative stress and DNA damage in human carcinogenesis. Mutat. Res. 2011, 711:193-201.
165. Sage E., Harrison L. Clustered DNA lesion repair in eukaryotes: relevance to mutagenesis and cell survival. Mutat. Res. 2011, 711:123-133.
166. Eccles L.J., O'Neill P., Lomax M.E. Delayed repair of radiation induced clustered DNA damage: friend or foe?. Mutat. Res. 2011, 711:134-141.